78.34
0.56 (0.72%)
0.56 (0.72%)
Upgrade to Real-Time
Afterhours (Closed)
Low
71.715
High
87.80
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.56 | 0.72% | 78.34 | 19:38:38 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 77.81 | 77.81 | 78.66 | 78.41 | 77.78 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 81,774 | 11,643,369 | $ 78.25 | $ 911,092,879 | 11,156,506 | 71.715 - 87.80 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:56:24 | 65 | $ 78.32 | USD |
Merck Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 198.30B | 2.53B | 2.53B | $ 48.00B | $ 7.05B | 2.77 | 27.00 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 2.48 | 3.17% | 274.58k | 0.10% |
Merck News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 73.58 | 78.66 | 73.48 | 76.34 | 13,485,360 | 4.76 | 6.47% |
| 1 Month | 75.51 | 79.49 | 72.85 | 76.62 | 11,700,485 | 2.83 | 3.75% |
| 3 Months | 74.72 | 79.49 | 71.715 | 75.84 | 12,368,792 | 3.62 | 4.84% |
| 6 Months | 84.94 | 85.60 | 71.715 | 77.76 | 10,905,424 | -6.60 | -7.77% |
| 1 Year | 77.00 | 87.80 | 71.715 | 78.83 | 9,860,019 | 1.34 | 1.74% |
| 3 Years | 57.77 | 92.64 | 56.255 | 77.82 | 10,086,996 | 20.57 | 35.61% |
| 5 Years | 53.57 | 92.64 | 52.83 | 71.15 | 9,798,429 | 24.77 | 46.24% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
